Shire Opts Not To Sue Teva Over Adderall XR ANDA

Law360, New York (April 12, 2005, 12:00 AM EDT) -- Shire Pharmaceuticals Group has decided not to sue Israeli generics maker Teva Pharmaceuticals USA Inc. over its application for a generic version of the best-selling attention deficit drug Adderall XR.

In February, Shire said that it had received a Paragraph IV Notice letter from Teva advising of the filing of an Abbreviated New Drug Application for its amphetamine combination product, a generic version of Shire's Adderall XR, a mixed amphetamine salts product.

Shire has filed lawsuits against generics makers Barr Laboratories and Impax, the first two...
To view the full article, register now.